PIPELINE
LEADERSHIP
- Management Team
- Board of Directors
MEDICAL AFFAIRS
NEWS & INVESTORS
CAREERS
CONTACT

February 2021

February 2021

February 18, 2021

Positive Data from PSOARING 3 Support Long-Term Us ...

Read More

Recent Posts

Dermavant Showcases New Long-Term Durability and Tolerability Data from Phase 3 PSOARING 3 Trial of Tapinarof Cream for Adults with Plaque Psoriasis at the 2022 AAD Annual Meeting
Dermavant to Present New Data from the Phase 3 PSOARING 3 Long-Term Extension Trial of Tapinarof Cream for Adults with Plaque Psoriasis at the 2022 American Academy of Dermatology Annual Meeting
Dermavant Appoints Nancy Beesley to its Board of Directors
Dermavant Presents New Patient Satisfaction Data from PSOARING 3 Long Term Extension Trial of Tapinarof in Adults with Plaque Psoriasis at the 2022 Winter Clinical Dermatology Conference
Dermavant to Present New Data from Phase 3 PSOARING Program at the 2022 Winter Clinical Dermatology Conference

Archives

Categories

Dermavant Sciences
News
RVT-201
RVT-501
RVT-502
RVT-504
Tapinarof

Find Us

Address
123 Main Street
New York, NY 10001

Hours
Monday—Friday: 9:00AM–5:00PM
Saturday & Sunday: 11:00AM–3:00PM

Copyright © 2018 Dermavant Sciences, Inc. All rights reserved.
Privacy Policy | Terms of Use

Pipeline
Leadership
- Management Team
- Board of Directors
Medical Affairs
News & Investors
Careers
Compliance Program
Contact

Copyright © 2022 Dermavant Sciences, Inc. All Rights Reserved. All trademarks are the property of Dermavant Sciences, GmbH.

Privacy Policy | Terms of Use | Terms of Sale – Independent Pharmacies | Terms of Sale – Wholesalers | US Wholesalers